ELITE PHARMACEUTICALS INC Warrant Agreements
5 Contracts & Agreements
- Series J Preferred Stock and Series J Common Stock Purchase Warrant anti-dilution waiver (Filed With SEC on August 14, 2020)
- COMMON STOCK PURCHASE WARRANT ElitePharmaceuticals, inc. (Filed With SEC on April 28, 2017)
- Elite Pharmaceuticals, Inc. Warrant To Purchase Common Stock (Filed With SEC on January 5, 2012)
- WARRANT TO PURCHASE 40,000,000 SHARES OF COMMON STOCK OF ELITE PHARMACEUTICALS, INC. Exercise Price: $0.0625 per share, subject to adjustment as provided below (the "Exercise... (Filed With SEC on June 5, 2009)
- COMMON STOCK PURCHASE WARRANT To Purchase 75,000 Shares of Common Stock of ELITE PHARMACEUTICALS, INC. (Filed With SEC on November 14, 2007)
